Bellerophon Therapeutics Stock (OTC:BLPH), Quotes and News Summary

Q: What sector and industry does Bellerophon Therapeutics (BLPH) operate in?

Bellerophon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.

Bellerophon Therapeutics Stock (OTC: BLPH) stock price, news, charts, stock research, profile.

Open	$0.055
Close	$0.055
Volume / Avg.	1.159K / 51.367K
Day Range	0.055 - 0.055
52 Wk Range	0.029 - 11.480
Market Cap	$666.679K
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Recent News

Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.

Lisa Levin

Dow Jumps Over 200 Points; JPMorgan Earnings Top Estimates

U.S. stocks traded mostly higher this morning, with the Dow Jones gaining more than 200 points on Friday. Following the market opening Friday, the Dow traded up 0.74% to 33,880.85 while the NASDAQ rose 0.04% to 13,579.61. The S&P 500 also rose, gaining, 0.41% to 4,367.33.

Lisa Levin

Why Coursera Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

Gainers Unique Fabricating, Inc. (NASDAQ: UFAB) shares surged 62.6% to $0.3512 in pre-market trading after gaining 12% on Thursday.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

About Bellerophon Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Bellerophon Therapeutics Inc is a clinical-stage therapeutics company. The firm develops innovative ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Bellerophon Therapeutics (BLPH) stock?

You can purchase shares of Bellerophon Therapeutics (OTCPK: BLPH) through any online brokerage.

View our list of the best stock brokerages.

Who are Bellerophon Therapeutics's (BLPH) competitors?

There are no as such competitors for Bellerophon Therapeutics.

What is the target price for Bellerophon Therapeutics (BLPH) stock?

The latest price target for Bellerophon Therapeutics (OTCPK: BLPH) was reported by HC Wainwright & Co. on Tuesday, June 6, 2023. The analyst firm set a price target for 2.00 expecting BLPH to rise to within 12 months (a possible 3569.72% upside). 4 analyst firms have reported ratings in the last year.

Current Stock Price for Bellerophon Therapeutics (BLPH)?

The stock price for Bellerophon Therapeutics (OTCPK: BLPH) is $0.0545 last updated April 17, 2024 at 10:49 AM EDT.

Does Bellerophon Therapeutics (BLPH) pay a dividend?

There are no upcoming dividends for Bellerophon Therapeutics.

When is Bellerophon Therapeutics (OTCPK:BLPH) reporting earnings?

Bellerophon Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.

Is Bellerophon Therapeutics (BLPH) going to split?

There is no upcoming split for Bellerophon Therapeutics.

What sector and industry does Bellerophon Therapeutics (BLPH) operate in?

Bellerophon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.